“The global neurovascular devices/interventional neurology market is poised to reach ~$2,370.4 million by 2020, growing at a CAGR of 8.4% from 2015 to 2020. North America is expected to hold the largest share of 47.3% of the global market in 2015. Market growth is being propelled by growing target patient population, technological advancements in the field of interventional neurosurgeries, favorable medical reimbursement scenario across mature markets, and expanding healthcare infrastructure in developing countries. However, factors such as ongoing healthcare reforms in the U.S. and a dearth of skilled neurosurgeons are restraining the growth of this market. In addition, stringent regulatory policies (that regulate product development and commercialization) across major markets are posing significant challenges for the growth of the neurovascular devices/interventional neurology market during the forecast period.
In this report, the global neurovascular devices/interventional neurology market is segmented on the basis of technology (embolization & coiling, carotid artery angioplasty & stenting, supporting techniques, and neurothrombectomy) and product (cerebral balloon angioplasty & stenting systems, aneurysm coiling & embolization devices, support devices, and neurothrombectomy devices). The aneurysm coiling and embolization devices segment is expected to account for the largest share of the global neurovascular devices/interventional neurology market in 2015, followed by cerebral balloon angioplasty & stenting systems. The cerebral balloon angioplasty & stenting systems segment is expected to grow at the highest CAGR during the next five years owing to factors such as an increasing number of researches, rising public-private funding to develop novel carotid stents & occlusion catheter products, and growing availability of technologically advanced stents & embolic protection devices across major markets (such as Europe, Japan, and the U.S.).
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global neurovascular devices/interventional neurology market in 2015, followed by Europe. Asia-Pacific is also poised to grow at the highest CAGR during the forecast period, owing to factors such as the presence of a large patient population base for target diseases, rising awareness among neurosurgeons (related to benefits offered by interventional neurology devices during neurosurgery), ongoing government initiatives to modernize & expand respective healthcare infrastructure, and increasing adoption due to decreasing prices of interventional neurology devices in Asia-Pacific.
The global neurovascular devices/interventional neurology market is moderately competitive, with various global as well as local players. In 2014, the global neurovascular devices/interventional neurology devices market was dominated by Stryker Corporation (U.S.), Medtronic, plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), and Penumbra, Inc. (U.S.), which together accounted for ~87.0% of the neurovascular devices/interventional neurology market. Geographic expansion, strategic acquisitions, new product launches, agreements, and collaborations are the major strategies adopted by most market players to achieve growth in the global neurovascular devices/interventional neurology market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the neurovascular devices/interventional neurology market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
โข Market Penetration: Comprehensive information on the neurovascular devices/interventional neurology products offered by the top 10 players in the global market. The report analyzes the neurovascular devices/interventional neurology market by product, application, and end user across key geographic regions
โข Product Development/Innovation: Detailed insights on upcoming neurovascular devices/interventional neurology technologies, research and development activities, and new product launches in the market
โข Market Development: Comprehensive information on lucrative emerging markets. The report analyzes the markets for various neurovascular devices/interventional neurology products across key geographic regions
โข Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global neurovascular devices/interventional neurology market
โข Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global neurovascular devices/interventional neurology market
”
“TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 GEOGRAPHIC SCOPE 17
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Breakdown of primaries 22
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 RESEARCH ASSUMPTIONS 25
2.4.1 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
3.1 INTRODUCTION 26
3.2 CURRENT MARKET SCENARIO 26
3.3 FUTURE OUTLOOK 28
3.4 CONCLUSION 31
4 PREMIUM INSIGHTS 32
4.1 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET OVERVIEW (2015โ2020) 32
4.2 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY TECHNOLOGY (2015) 33
4.3 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCT TYPE (2015-2020) 34
4.4 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY PRODUCT (2015) 35
4.5 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY PRODUCT (UNITS) 36
4.6 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY REGION (2015-2020) 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 39
5.2 MARKET SEGMENTATION 39
5.3 MARKET DYNAMICS 40
5.3.1 KEY MARKET DRIVERS 41
5.3.1.1 Growing target patient population 42
5.3.1.2 Technological advancements 43
5.3.1.3 Favorable medical reimbursements 44
5.3.1.4 Expansion of healthcare infrastructure across developing countries 44
5.3.1.5 Growing market demand for effective neurovascular devices 45
5.3.2 KEY MARKET RESTRAINTS 46
5.3.2.1 Ongoing healthcare reforms in the U.S. 46
5.3.2.2 Dearth of skilled neurosurgeons 47
5.3.3 KEY MARKET OPPORTUNITIES 47
5.3.3.1 Growing market penetration of key players in emerging countries 48
5.3.3.2 Increasing research in neurovascular therapies 48
5.3.3.3 Rising demand for minimally invasive neurosurgical procedures 49
5.3.4 KEY MARKET CHALLENGE 50
5.3.4.1 Stringent regulatory policies 50
5.4 ONGOING CLINICAL STUDIES 51
5.4.1 EMBOLIZATION COILING PROCEDURES 51
5.4.2 CAROTID ARTERY STENTING PROCEDURES 53
5.4.3 EMBOLIC PROTECTION PROCEDURES 57
5.4.4 FLOW DIVERSION PROCEDURES 58
5.4.5 SUPPORTING TECHNIQUES 59
5.4.6 NEUROTHROMBECTOMY PROCEDURES 59
6 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY TECHNOLOGY 62
6.1 INTRODUCTION 63
6.2 EMBOLIZATION AND COILING 64
6.3 CAROTID ARTERY ANGIOPLASTY AND STENTING 65
6.4 SUPPORTING TECHNIQUES 66
6.5 NEUROTHROMBECTOMY 68
7 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY PRODUCT 69
7.1 INTRODUCTION 70
7.2 ANEURYSM COILING AND EMBOLIZATION DEVICES 72
7.2.1 EMBOLIC COILS 74
7.2.1.1 Bare Detachable Coils 75
7.2.1.2 Coated Detachable Coils 76
7.2.2 FLOW DIVERSION DEVICES 77
7.2.3 LIQUID EMBOLIC AGENTS 78
7.3 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 79
7.3.1 CAROTID ARTERY STENTS 81
7.3.2 EMBOLIC PROTECTION SYSTEMS 83
7.3.2.1 Distal Filter Devices 84
7.3.2.2 Balloon Occlusion Devices 85
7.4 SUPPORT DEVICES 87
7.4.1 MICROCATHETERS 88
7.4.2 MICROGUIDEWIRES 90
7.5 NEUROTHROMBECTOMY DEVICES 91
7.5.1 CLOT RETRIEVAL DEVICES 93
7.5.2 SUCTION AND ASPIRATION DEVICES 94
7.5.3 SNARES 95
8 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY REGION 97
8.1 INTRODUCTION 98
8.2 NORTH AMERICA 100
8.2.1 U.S. 103
8.3 EUROPE 105
8.4 ASIA-PACIFIC 109
8.4.1 JAPAN 113
8.5 REST OF THE WORLD (ROW) 114
9 COMPETITIVE LANDSCAPE 118
9.1 OVERVIEW 118
9.2 MARKET SHARE ANALYSIS 119
9.3 COMPETITIVE SCENARIO 121
9.4 RECENT DEVELOPMENTS 123
9.4.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 123
9.4.2 GEOGRAPHICAL EXPANSIONS 124
9.4.3 STRATEGIC ACQUISITIONS 126
9.4.4 AGREEMENTS AND PARTNERSHIPS 127
9.4.5 OTHER DEVELOPMENTS 128
10 COMPANY PROFILES 129
(Overview, Financials, Products, Strategy, & Developments)*
10.1 INTRODUCTION 129
10.1.1 GEOGRAPHIC MIX 129
10.1.2 STRATEGIC BENCHMARKING 130
10.2 STRYKER CORPORATION 131
10.3 MEDTRONIC PLC 134
10.4 JOHNSON & JOHNSON 139
10.5 TERUMO CORPORATION 143
10.6 PENUMBRA, INC. 147
10.7 ABBOTT LABORATORIES 150
10.8 MERIT MEDICAL SYSTEMS, INC. 152
10.9 W. L. GORE & ASSOCIATES, INC. 154
10.10 MICROPORT SCIENTIFIC CORPORATION 155
10.11 MEDIKIT CO., LTD. 157
*Details on Financials, Products, Strategy, & Developments might not be captured in case of unlisted companies.
11 APPENDIX 158
11.1 INSIGHTS OF INDUSTRY EXPERTS 158
11.2 DISCUSSION GUIDE 159
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 164
11.4 AVAILABLE CUSTOMIZATIONS 164
11.5 RELATED REPORTS 165
“
“LIST OF TABLES
TABLE 1 GROWING TARGET PATIENT POPULATION IS RESULTING IN HIGHER MARKET DEMAND FOR NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY PRODUCTS 41
TABLE 2 DEARTH OF SKILLED NEUROSURGEONS HINDERING THE ADOPTION OF NEUROVASCULAR DEVICES AMONG HEALTHCARE PROFESSIONALS 46
TABLE 3 GROWTH POTENTIAL IN EMERGING MARKETS 47
TABLE 4 STRINGENT REGULATORY FRAMEWORK THREATENING OVERALL MARKET GROWTH 50
TABLE 5 EMBOLIZATION COILS: ONGOING CLINICAL TRIALS (AS OF 2015) 51
TABLE 6 CAROTID STENTS: ONGOING CLINICAL TRIALS (AS OF 2015) 53
TABLE 7 DISTAL FILTER AND BALLOON OCCLUSION CATHETERS: ONGOING CLINICAL TRIALS (AS OF 2015) 57
TABLE 8 FLOW DIVERSION DEVICES: ONGOING CLINICAL TRIALS (AS OF 2015) 58
TABLE 9 MICROCATHETERS: ONGOING CLINICAL TRIALS (AS OF 2015) 59
TABLE 10 CLOT RETRIEVAL, SUCTION, AND ASPIRATION DEVICES: ONGOING CLINICAL TRIALS (AS OF 2015) 59
TABLE 11 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY TECHNOLOGY, 2013โ2020 (USD MILLION) 63
TABLE 12 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIZATION AND COILING, BY REGION, 2013โ2020 (USD MILLION) 65
TABLE 13 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR CAROTID ARTERY ANGIOPLASTY AND STENTING, BY REGION,
2013โ2020 (USD MILLION) 66
TABLE 14 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORTING TECHNIQUES, BY REGION, 2013โ2020 (USD MILLION) 67
TABLE 15 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR NEUROTHROMBECTOMY, BY REGION, 2013โ2020 (USD MILLION) 68
TABLE 16 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 71
TABLE 17 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY PRODUCT, 2013โ2020 (UNITS) 71
TABLE 18 ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013โ2020 (USD MILLION) 72
TABLE 19 ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013โ2020 (UNITS) 72
TABLE 20 ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 73
TABLE 21 EMBOLIC COILS MARKET SIZE, BY PRODUCT TYPE, 2013โ2020 (USD MILLION) 74
TABLE 22 EMBOLIC COILS MARKET SIZE, BY PRODUCT TYPE, 2013โ2020 (UNITS) 74
TABLE 23 EMBOLIC COILS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 75
TABLE 24 BARE DETACHABLE COILS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 75
TABLE 25 BARE DETACHABLE COILS MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 76
TABLE 26 COATED DETACHABLE COILS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 76
TABLE 27 COATED DETACHABLE COILS MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 77
TABLE 28 FLOW DIVERSION DEVICES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 77
TABLE 29 ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET VOLUME FOR FLOW DIVERSION DEVICES, BY REGION, 2013โ2020 (UNITS) 78
TABLE 30 LIQUID EMBOLIC AGENTS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 78
TABLE 31 LIQUID EMBOLIC AGENTS MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 79
TABLE 32 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE,
BY PRODUCT TYPE, 2013โ2020 (USD MILLION) 79
TABLE 33 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE,
BY PRODUCT TYPE, 2013โ2020 (UNITS) 80
TABLE 34 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE,
BY REGION, 2013โ2020 (USD MILLION) 80
TABLE 35 CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 82
TABLE 36 CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 82
TABLE 37 EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013โ2020 (USD MILLION) 83
TABLE 38 EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013โ2020 (UNITS) 83
TABLE 39 EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 84
TABLE 40 DISTAL FILTER DEVICES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 84
TABLE 41 DISTAL FILTER DEVICES MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 85
TABLE 42 BALLOON OCCLUSION DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 86
TABLE 43 BALLOON OCCLUSION DEVICES MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 86
TABLE 44 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 87
TABLE 45 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013โ2020 (USD MILLION) 88
TABLE 46 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013โ2020 (UNITS) 88
TABLE 47 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROCATHETERS MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 89
TABLE 48 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROCATHETERS MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 89
TABLE 49 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROGUIDEWIRES MARKET SIZE, BY REGION, 2013โ2020 (USD MILLION) 90
TABLE 50 NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROGUIDEWIRES MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 90
TABLE 51 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013โ2020 (USD MILLION) 92
TABLE 52 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013โ2020 (UNITS) 92
TABLE 53 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 92
TABLE 54 NEUROTHROMBECTOMY CLOT RETRIEVAL DEVICES MARKET SIZE,
BY REGION, 2013โ2020 (USD MILLION) 93
TABLE 55 NEUROTHROMBECTOMY CLOT RETRIEVAL DEVICES MARKET SIZE,
BY REGION, 2013โ2020 (UNITS) 94
TABLE 56 NEUROTHROMBECTOMY SUCTION & ASPIRATION DEVICES MARKET SIZE,
BY REGION, 2013โ2020 (USD MILLION) 94
TABLE 57 NEUROTHROMBECTOMY SUCTION & ASPIRATION DEVICES MARKET SIZE,
BY REGION, 2013โ2020 (UNITS) 95
TABLE 58 NEUROTHROMBECTOMY SNARES MARKET SIZE, BY REGION,
2013โ2020 (USD MILLION) 95
TABLE 59 NEUROTHROMBECTOMY SNARES MARKET SIZE, BY REGION, 2013โ2020 (UNITS) 96
TABLE 60 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY REGION, 2013โ2020 (USD MILLION) 99
TABLE 61 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013โ2020 (USD MILLION) 102
TABLE 62 NORTH AMERICA: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 102
TABLE 63 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 102
TABLE 64 NORTH AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 103
TABLE 65 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 103
TABLE 66 U.S.: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY TECHNOLOGY, 2013โ2020 (USD MILLION) 104
TABLE 67 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013โ2020 (USD MILLION) 107
TABLE 68 EUROPE: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 107
TABLE 69 EUROPE: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 107
TABLE 70 EUROPE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 108
TABLE 71 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 108
TABLE 72 ASIA-PACIFIC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013โ2020 (USD MILLION) 111
TABLE 73 ASIA-PACIFIC: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 111
TABLE 74 ASIA-PACIFIC: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 111
TABLE 75 ASIA-PACIFIC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 112
TABLE 76 ASIA-PACIFIC: NEUROTHROMBECTOMY DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 112
TABLE 77 JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013โ2020 (USD MILLION) 113
TABLE 78 ROW: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE,
BY TECHNOLOGY, 2013โ2020 (USD MILLION) 116
TABLE 79 ROW: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE,
BY PRODUCT, 2013โ2020 (USD MILLION) 116
TABLE 80 ROW: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 116
TABLE 81 ROW: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2013โ2020 (USD MILLION) 117
TABLE 82 ROW: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT,
2013โ2020 (USD MILLION) 117
TABLE 83 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012โ2015 123
TABLE 84 GEOGRAPHICAL EXPANSIONS, 2012โ2015 124
TABLE 85 STRATEGIC ACQUISITIONS, 2012โ2015 126
TABLE 86 AGREEMENTS AND PARTNERSHIPS, 2012โ2015 127
TABLE 87 OTHER DEVELOPMENTS, 2012โ2015 128
“
“LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BOTTOM-UP APPROACH 23
FIGURE 3 TOP-DOWN APPROACH 23
FIGURE 4 DATA TRIANGULATION 24
FIGURE 5 ASSUMPTIONS FOR THE RESEARCH STUDY 25
FIGURE 6 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, BY KEY PLAYER, 2014 27
FIGURE 7 FUTURE TRENDS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY (2015โ2020) 28
FIGURE 8 FUTURE TRENDS: NEUROVASCULAR DEVICES AND INTERVENTIONAL NEUROLOGY MARKET SHARE, BY PRODUCT (2015 VS. 2020) 29
FIGURE 9 FUTURE TRENDS: NEUROVASCULAR DEVICES AND INTERVENTIONAL NEUROLOGY PRODUCTS MARKET SIZE, BY TYPE (2015โ2020) 29
FIGURE 10 FUTURE TRENDS: CAROTID BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT TYPE (2015โ2020) 30
FIGURE 11 FUTURE TRENDS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, BY REGION (2015) 31
FIGURE 12 ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 32
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE INTERVENTIONAL NEUROLOGY TECHNOLOGIES MARKET IN 2015 33
FIGURE 14 CAROTID STENTS & FLOW DIVERSION DEVICES SEGMENTS ARE EXPECTED TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 34
FIGURE 15 ANEURYSM COILING AND EMBOLIZATION DEVICES IS THE KEY PRODUCT SEGMENT ACROSS ALL REGIONS IN 2015 35
FIGURE 16 CAROTID STENTS & FLOW DIVERSION DEVICES ARE POISED TO BE THE FASTEST-GROWING PRODUCT SEGMENTS TILL 2020 36
FIGURE 17 ASIA-PACIFIC IS POISED TO BE THE FASTEST GROWING REGION IN NEUROVASCULAR DEVICE/INTERVENTIONAL NEUROLOGY MARKET TILL 2020 37
FIGURE 18 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 19 PROPORTION OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, (2012 VS. 2020) 43
FIGURE 20 GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010โ2012) 45
FIGURE 21 ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS IN 2015) 49
FIGURE 22 CAROTID ARTERY ANGIOGRAPHY & STENTING IS POISED TO BE THE FASTEST-GROWING NEUROVASCULAR TECHNOLOGY DURING FORECAST PERIOD 63
FIGURE 23 NORTH AMERICA IS EXPECTED TO BE THE LARGEST GEOGRAPHIC SEGMENT IN THE GLOBAL SUPPORTING TECHNIQUES MARKET (2015) 67
FIGURE 24 BALLOON ANGIOGRAPHY & STENTING SYSTEMS MARKET TO WITNESS HIGHEST GROWTH AMONG ALL PRODUCTS CATEGORIES DURING 2015 TO 2020 70
FIGURE 25 EMBOLIC COILS SEGMENT EXPECTED TO LEAD ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET DURING THE FORECAST PERIOD 73
FIGURE 26 CAROTID STENTS TO WITNESS HIGHEST GROWTH IN THE CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET 81
FIGURE 27 MICROCATHETERS TO HOLD THE LARGEST SHARE OF SUPPORTING DEVICES MARKET DURING THE STUDY PERIOD 87
FIGURE 28 CLOT RETRIEVERS SEGMENT TO WITNESS SIGNIFICANT GROWTH IN NEUROTHROMBECTOMY DEVICES MARKET 91
FIGURE 29 NORTH AMERICA TO LEAD THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DURING 2015โ2020 98
FIGURE 30 NORTH AMERICAN MARKET SNAPSHOT: RISING NUMBER OF CLINICAL TRIALS TO AUGMENT THE ADOPTION OF NEUROVASCULAR DEVICES 101
FIGURE 31 EUROPEAN MARKET SNAPSHOT: GROWING AVAILABILITY OF INNOVATIVE NEUROVASCULAR DEVICES TO SUPPORT MARKET GROWTH 106
FIGURE 32 ASIA-PACIFIC MARKET SNAPSHOT: INCREASING LOCALIZED MANUFACTURING TO PROPEL DEMAND FOR NEUROVASCULAR DEVICES 110
FIGURE 33 ROW MARKET SNAPSHOT: LOW AWARENESS LIMITING MARKET EXPANSION 115
FIGURE 34 NEW PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS WAS ADOPTED BY MOST OF THE LEADING PLAYERS TO STRENGTHEN THEIR MARKET POSITIONS BETWEEN 2012 AND 2015 118
FIGURE 35 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, BY KEY PLAYER, 2014 119
FIGURE 36 RANKING OF MARKET PLAYERS, BY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SEGMENT (2014) 120
FIGURE 37 CONTINUOUS PRODUCT DEVELOPMENT & COMMERCIALIZATION IS STIMULATING MARKET COMPETITION AMONG KEY PLAYERS 121
FIGURE 38 GEOGRAPHIC REVENUE MIX OF TOP FOUR MARKET PLAYERS* 129
FIGURE 39 LEADING COMPANIES FOCUS ON GEOGRAPHIC EXPANSIONS TO STRENGTHEN THEIR DISTRIBUTION NETWORKS & DEVICE MANUFACTURING CAPABILITIES 130
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT 131
FIGURE 41 MEDTRONIC PLC: COMPANY SNAPSHOT 134
FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT 139
FIGURE 43 TERUMO CORPORATION: COMPANY SNAPSHOT 143
FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT 150
FIGURE 45 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 152
FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 155
“
